Filing Details

Accession Number:
0001022079-22-000131
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-04 16:34:53
Reporting Period:
2022-10-03
Accepted Time:
2022-10-04 16:34:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204666 M Timothy Ring 500 Plaza Drive
Secaucus NJ 07094
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-03 2,000 $61.23 25,933 No 4 M Direct
Common Stock Disposition 2022-10-03 2,000 $123.39 23,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2022-10-03 2,000 $61.23 2,000 $61.23
Common Stock Phantom Stock Units Acquisiton 2022-10-03 333 $0.00 333 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
260 2023-05-21 No 4 M Direct
12,748 No 4 A Direct
Footnotes
  1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 1, 2022.
  2. The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.
  3. Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
  4. Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.